The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model.

Source:http://linkedlifedata.com/resource/pubmed/id/20802826

Download in:

View as

General Info

PMID
20802826